Literature DB >> 11993741

Lennox-Gastaut syndrome. Clinical description and diagnosis.

Ernst Niedermeyer.   

Abstract

The Lennox-Gastaut syndrome (LGS) is widely known as one of the most severe and prognostically unfavourable epileptic conditions. Its entity as a syndrome is based on the occurrence of certain characteristic types of seizure (particularly typical drop attacks and axial tonic seizures) and on EEG patterns such as the slow spike-wave complex and runs of rapid spikes (10-25/sec).

Entities:  

Mesh:

Year:  2002        PMID: 11993741

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Ionic dynamics mediate spontaneous termination of seizures and postictal depression state.

Authors:  Giri P Krishnan; Maxim Bazhenov
Journal:  J Neurosci       Date:  2011-06-15       Impact factor: 6.167

2.  Dynamics of epileptiform activity in mouse hippocampal slices.

Authors:  Gregory Filatov; Giri P Krishnan; Nikolai F Rulkov; Maxim Bazhenov
Journal:  J Biol Phys       Date:  2011-02-02       Impact factor: 1.365

3.  Maintenance and termination of neocortical oscillations by dynamic modulation of intrinsic and synaptic excitability.

Authors:  Flavio Fröhlich; Maxim Bazhenov; Igor Timofeev; Terrence J Sejnowski
Journal:  Thalamus Relat Syst       Date:  2005-06-01

4.  Network bistability mediates spontaneous transitions between normal and pathological brain states.

Authors:  Flavio Fröhlich; Terrence J Sejnowski; Maxim Bazhenov
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

Review 5.  Lennox-Gastaut syndrome. Management update.

Authors:  Muradi H Al-Banji; Doaa K Zahr; Mohammed M Jan
Journal:  Neurosciences (Riyadh)       Date:  2015-07       Impact factor: 0.906

6.  Potassium model for slow (2-3 Hz) in vivo neocortical paroxysmal oscillations.

Authors:  M Bazhenov; I Timofeev; M Steriade; T J Sejnowski
Journal:  J Neurophysiol       Date:  2004-03-31       Impact factor: 2.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.